Text Size: A+| A-| A   |   Text Only Site   |   Accessibility
Department of Human Services

Understanding OSCaR Data


The brochure, Understanding OSCaR Data, explains current methods used in the data analysis of Cancer in Oregon.
  • Understanding OSCaR Data

    These data represent the cancers that are reportable to OSCaR:

    • All invasive malignant neoplasms, except basal and squamous cell carcinoma of the skin.

    • All in-situ carcinomas, except carcinoma in-situ of the cervix uteri, and basal and squamous cell carcinoma in-situ of the skin.

    • All non-malignant primary intracranial and central nervous system tumors

In analyzing Oregon's cancer data, we looked at various measures commonly used in epidemiologic studies of cancer.

  • One measure is the incidence rate, which provides information on the frequency with which cases are occurring in the population over time. Another measure is the mortality rate, which is the rate of deaths due to cancer in the Oregon population.

  • Annual crude incidence rates are calculated as the total number of newly diagnosed cases divided by the overall population of Oregon.

  • Age-adjusted rates are calculated to allow comparisons between two different populations (i.e., Oregon and the U.S.) whose age distributions differ.

  • As a measure of disease severity and/or prognosis, we include the mortality-to-incidence (M/I) ratio. Under conditions of stable rates, the M/I ratio may be considered as the chance of eventually dying from a specific cancer (at current cure rates). Values closer to 0 indicate a good prognosis; values closer to 1 indicate a poor prognosis.
Mortality and Incidence Queriable Databases

For more information, please contact:

oscar.ohd@state.or.us

 
Page updated: April 10, 2008

Get Adobe Acrobat ReaderAdobe Reader is required to view PDF files. Click the "Get Adobe Reader" image to get a free download of the reader from Adobe.